A couple of things about Cpn10. The original trials were not done under US IND so new safety data is required. There was only a limited amount of drug scrounged by the new management, so a large trial was not possible. They need a new supply of drug which requires a lot of capital. The management are doing a very good job with what is available. The results will be positive.
What's the next significant announcement ?, page-21
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.41M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $13.85K | 3.463M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 9749314 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 6055724 | 26 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |